XERS
Xeris Biopharma Holdings Inc.
Latest News for XERS
Oppenheimer analyst reiterated a Buy rating on Xeris Pharmaceuticals today and set a price target of $18.00. Currently, the analyst consensus on Xe......
Oppenheimer analyst reiterated a Buy rating on Xeris Pharmaceuticals today and set a price target of $18.00. Currently, the analyst consensus on Xe......
H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Xeris Pharmaceuticals today and set a price target of $10.00. Folkes covers the H......
H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Xeris Pharmaceuticals today and set a price target of $10.00. Folkes covers the H......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xeris Pharmaceuticals (XERS) and Tarsus Pharmaceutic......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XERS | $6.32 | +1.4% | 1.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xeris Biopharma Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW